APRIL 8 – APRIL 13, 2022 American Association for Cancer Research (AACR) Annual Meeting
Presentation Title: AUR103 an oral small molecule CD47 antagonist in combination with azacytidine and bortezomib exhibits potent anti-tumor activity in myeloma and leukemia models in vitro and in vivo Session Title: Immunomodulatory Agents and Interventions 2 Session Category: Immunology Abstract Number: 3500 Link: https://www.abstractsonline.com/pp8/#!/10517/presentation/17070
Presentation Title: Evaluation of AU-18069, a novel small molecule CBP/p300 bromodomain inhibitor for the treatment of cancers Session Title: Precision Oncology / Surgical Oncology Session Category: Clinical Research Excluding Trials Abstract Number: 4114 Link: https://www.abstractsonline.com/pp8/#!/10517/presentation/21612
Presentation Title: Discovery of orally bioavailable SMARCA2/4 dual degraders for treatment of acute myeloid leukemia Session Title: Chromatin Modifiers: Mutations and Novel Therapeutics Session Category: Molecular/Cellular Biology and Genetics Abstract Number: 3729 Link: https://www.abstractsonline.com/pp8/#!/10517/presentation/17274
Presentation Title: Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer Session Title: Small Molecule Therapeutic Agents Session Category: Experimental and Molecular Therapeutics Abstract Number: 5469 Link: https://www.abstractsonline.com/pp8/#!/10517/presentation/18614
Presentation Title: Targeting SWI/SNF ATPases in enhancer-addicted human cancers Session Title: Promising New Therapies Session Category: Experimental and Molecular Therapeutics (Mini symposium) Abstract Number: 3592 Link: https://www.abstractsonline.com/pp8/#!/10517/presentation/11996